A. Fabre (Dublin 4, Ireland), G. Beltramo (Dijon, France)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients
K. Paschalaki (London, United Kingdom), C. Rossios (London, United Kingdom), V. Gorgoulis (Athens, Greece), A. Randi (London, United Kingdom), P. Barnes (London, United Kingdom)
|    |
Proteomics approach to identify COPD-related changes in pulmonary fibroblasts
N. Bekker (Groningen, Netherlands), A. Van Pijkeren (Groningen, Netherlands), J. Wolters (Groningen, Netherlands), A. Sánchez Brotons (Groningen, Netherlands), V. Guryev (Groningen, Netherlands), R. Bischoff (Groningen, Netherlands), W. Alkema (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), P. Horvatovich (Groningen, Netherlands), W. Timens (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands)
| |
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
P. Bhattarai (Tasmania, Australia), W. Lu (Tasmania, Australia), J. Markos (Tasmania, Australia), C. Chia (Tasmania, Australia), J. Larby (Tasmania, Australia), G. Haug (Tasmania, Australia), A. Williams (Tasmania, Australia), S. Myers (Tasmania, Australia), A. Hardikar (Tasmania, Australia), A. Gaikwad (Tasmania, Australia), S. Dey (Tasmania, Australia), G. Singhera (British Columbia , Canada), T. Hackett (British Columbia , Canada), M. Eapen (Tasmania, Australia), S. Sohal (Tasmania, Australia)
| |
Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD
S. Brake (Launceston (TAS), Australia), W. Lu (Launceston (TAS), Australia), J. Markos (Launceston (TAS), Australia), J. Larby (Launceston (TAS), Australia), C. Chia (Launceston (TAS), Australia), G. Haug (Launceston (TAS), Australia), H. Weber (Launceston (TAS), Australia), K. Mcalinden (Launceston (TAS), Australia), A. Hardikar (Launceston (TAS), Australia), G. Singhera (Launceston (TAS), Canada), T. Hackett (Launceston (TAS), Canada), M. Eapen (Launceston (TAS), Australia), S. Sohal (Launceston (TAS), Australia)
| |
Association of the salivary microbiome with asthma exacerbations
J. Pérez García (Tenerife, Spain), A. Espuela-Ortiz (Tenerife, Spain), J. Hernandez-Perez (La Palma, Spain), R. González-Pérez (Tenerife, Spain), O. Sardón (San Sebastián, Spain), E. Martin-Gonzalez (Tenerife, Spain), E. Mederos-Luis (Tenerife, Spain), P. Corcuera (San Sebastián, Spain), I. Sánchez-Machín (Tenerife, Spain), P. Poza-Guedes (Tenerife, Spain), A. Callero (Tenerife, Spain), M. González (Tenerife, Spain), L. González García (La Palma, Spain), J. Korta-Murua (San Sebastián, Spain), J. Villar (Las Palmas, Spain), M. Pino-Yanes (Madrid, Spain), F. Lorenzo-Diaz (Tenerife, Spain), J. Perez-Garcia (San Cristóbal de La Laguna, Spain)
| |
USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
N. Cerón Pisa (Palma, Spain), A. Iglesias Coma (Palma, Spain), F. Verdú Rivera (Palma, Spain), J. Muncunill Farreny (Palma, Spain), J. Sauleda Roig (Palma, Spain)
| |
Impact of prematurity on rabbit lung development: a key factor for mimicking chronic neonatal lung disease
M. Storti (Parma, Italy), F. Ricci (Parma, Italy), C. Casiraghi (Parma, Italy), C. Catozzi (Parma, Italy), F. Ravanetti (Parma, Italy), L. Ragionieri (Parma, Italy), R. Ciccimarra (Parma, Italy), M. Zoboli (Parma, Italy), G. Villetti (Parma, Italy), M. Civelli (Parma, Italy), F. Salomone (Parma, Italy), B. Montanini (Parma, Italy), S. Ottonello (Parma, Italy)
| |
Diagnosis of Primary Ciliary Dyskinesia: a multi-center experience
R. Hjeij (Münster, Germany), S. Cindric (Münster, Germany), H. Olbrich (Münster, Germany), P. Pennekamp (Münster, Germany), N. Loges (Münster, Germany), G. Dougherty (Münster, Germany), J. Wallmeier (Münster, Germany), J. Raidt (Münster, Germany), H. Omran (Münster, Germany)
| |
Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT)
A. Gaikwad (Launceston (TAS), Australia), W. Lu (Launceston (TAS), Australia), S. Dey (Launceston (TAS), Australia), P. Bhattarai (Launceston (TAS), Australia), C. Chia (Launceston (TAS), Australia), J. Larby (Launceston (TAS), Australia), G. Haug (Launceston (TAS), Australia), S. Myers (Launceston (TAS), Australia), S. Brake (Launceston (TAS), Australia), J. Jaffar (Melbourne, Australia), G. Westall (Melbourne, Australia), G. Singhera (Vancouver, Canada), T. Hackett (Vancouver, Canada), J. Markos (Launceston (TAS), Australia), M. Eapen (Launceston (TAS), Australia), S. Sohal (Launceston (TAS), Australia)
| |
Late Breaking Abstract - Transcriptional response to RSV in asthma primary bronchial epithelial cells: are the basal cells responsible for the reduced NF-kB response?
A. Gay (Groningen, Netherlands), M. Berg (Groningen, Netherlands), O. Carpaij (Groningen, Netherlands), U. Brouwer (Groningen, Netherlands), D. Van Gosliga (Groningen, Netherlands), H. Aliee (Neuherberg, Germany), B. Lambrecht (Ghent, Belgium), M. Van Den Berge (Groningen, Netherlands), R. Hendriks (Rotterdam, Netherlands), G. Koppelman (Groningen, Netherlands), L. Bont (Utrecht, Netherlands), M. Nawijn (Groningen, Netherlands)
| |
Discussion
| |